MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?

Arjan Diepstra*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1740-1741
Number of pages2
JournalLeukemia and Lymphoma
Volume50
Issue number11
DOIs
Publication statusPublished - 2009

Keywords

  • POOR PATIENT SURVIVAL
  • PROTEIN EXPRESSION
  • DELETIONS
  • GENE

Cite this